Hansen Medical(R) to Highlight Role of Magellan(TM) Robotic System in Embolization Procedures and New Data on Reduced Radiation at Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Scientific Meeting

MOUNTAIN VIEW, CA--(Marketwired - Sep 21, 2015) - Hansen Medical^®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Scientific Meeting September 26-September 30 at Centro de Congressos de Lisboa in Lisbon, Portugal. The Company will showcase the Magellan 6Fr Robotic Catheter that is used by Interventional Radiologists in embolization procedures and will conduct Magellan Robotic System demonstrations at exhibit booth #54.

The meeting marks the 30^th anniversary of CIRSE and is the largest IR event of 2015. During this year's CIRSE meeting, Hansen Medical will host an educational speaker series at the Magellan booth to discuss how intravascular robotics is helping to advance embolization procedures and reduce radiation exposure. This series includes the following sessions:

• September 26, 11:00- Incorporating Intravascular Robotics in Embolization- Marc Sapoval, MD, PhD (Paris, France)
• September 26, 12:30 & September 27, 11:00- Experiences with Robotic Assisted UFE- Mohamad Hamady, MD (London, UK)
• September 27, 09:30 & September 28, 11:00- Update on PAE and Role for Robotics- Sandeep Bagla, MD (Alexandria, Virginia)
• September 28, 09:30- Robotic Catheter Assistance: The Relationship on Radiation Exposure- Barry Katzen, MD (Miami, Florida)
  
  

Hansen Medical is also highlighting its dedication to reducing radiation exposure for physicians, staff and patients. Hansen Medical is a sponsor of the second annual Radiation Protection Pavilion, which is an interactive awareness campaign for radiation protection and dose management in interventional radiology. At the pavilion, Dr. Katzen will discuss the role of robotic technology in reducing radiation exposure and will present on September 28 at 2:00pm local time.

Magellan is also featured in CIRSE's Product Launch portfolio, which highlights new data presented by Sandeep Rao, MD and Dr. Katzen indicating a greater than 90% physician radiation reduction during robotic-assisted endovascular procedures, as compared to manually performing a procedure at the bedside.

"We are looking forward to meeting with the CIRSE community and seeing Magellan physician users from around the world at the largest global Interventional Radiology meeting," said Cary Vance, Hansen Medical's President and Chief Executive Officer. "Current radiation reduction initiatives and recent advances in embolization procedures across Women's Health, Men's Health and Cancer treatments speak to a high level of innovation within the IR community. We are excited about the role that Magellan has had in these efforts and that Magellan has enabled physicians and patients to benefit from robotic precision, control and protection during embolization procedures."